fluorescein-5-isothiocyanate has been researched along with thromboplastin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evranova, GB; Popova, LG; Subkhankulova, FB; Zubairov, DM | 1 |
| Dachary-Prigent, J; Freyssinet, JM; Nurden, AT; Pasquet, JM | 1 |
| de Jong, K; Geldwerth, D; Kuypers, FA | 1 |
| Andree, HA; Calandri, C; Gascon-Lema, MG; Harpel, PC; Rand, JH; Ross, JB; Rusinova, E; Wu, XX | 1 |
| Chu, AJ; Fox, MJ; Prasad, JK | 1 |
| Castellanous, EJ; Ishibashi, H; Kaneda, Y; Nakagawa, K; Nakashima, Y; Onimaru, M; Shirasuna, K; Sueishi, K | 1 |
| Haufe, D; Knels, L; Koch, T; Kotzsch, M; Luther, T | 1 |
| Bevers, EM; Comfurius, P; Keuren, JF; Lindhout, T; Rasmussen, JT; Wolfs, JL; Zwaal, RF | 1 |
| Ammollo, CT; Esmon, CT; Esmon, NL; Semeraro, F | 1 |
| Ceng, R; Li, Q; Liang, H; Liang, W; Yang, Y; Zhang, W; Zhao, S | 1 |
10 other study(ies) available for fluorescein-5-isothiocyanate and thromboplastin
| Article | Year |
|---|---|
[Distribution and inactivation of tissue thromboplastin in the body].
Topics: Animals; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Half-Life; Rats; Thiocyanates; Thromboplastin; Time Factors; Tissue Distribution | 1988 |
Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors.
Topics: Annexin A5; Antibodies, Monoclonal; Blood Platelets; Blood Proteins; Calcium; Calcium-Transporting ATPases; Calpain; Coagulants; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Humans; Hydrolysis; Kinetics; Microspheres; Molecular Probes; P-Selectin; Phospholipids; Platelet Activation; Thromboplastin | 1995 |
Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes.
Topics: Aniline Compounds; Annexin A5; Calcimycin; Calcium; Erythrocyte Deformability; Erythrocyte Membrane; Ethylmaleimide; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydrogen Peroxide; Membrane Lipids; Oxidative Stress; Phenylhydrazines; Phosphatidylserines; Phospholipids; Sulfhydryl Reagents; Thromboplastin; Xanthenes | 1997 |
Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
Topics: Annexin A5; Antibodies, Antiphospholipid; Blood Coagulation; Blood Platelets; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunoglobulin G; Indicators and Reagents; Lipid Bilayers; Lupus Coagulation Inhibitor; Partial Thromboplastin Time; Phosphatidylserines; Phospholipids; Prothrombin Time; Thromboplastin | 1998 |
Extracellular Ca(2+) suppresses endotoxin-inducible tissue factor activation in monocytic THP-1 cells.
Topics: Antigens, CD; Blood Coagulation; Calcium; Cell Line; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Monocytes; Thromboplastin | 2000 |
Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities.
Topics: Adenocarcinoma; Binding Sites; Cell Division; Cell Movement; Endothelial Growth Factors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glioblastoma; Humans; Liposomes; Lung Neoplasms; Lymphokines; Neoplasm Invasiveness; Oligonucleotides; Respirovirus; RNA, Messenger; Sp1 Transcription Factor; Thromboplastin; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Perfluorocarbon attenuates response of concanavalin A-stimulated mononuclear blood cells without altering ligand-receptor interaction.
Topics: Biocompatible Materials; Cell Membrane; Concanavalin A; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluorocarbons; Humans; Interleukin-2; Microscopy, Fluorescence; Monocytes; Receptors, Cell Surface; Thromboplastin | 2004 |
Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Topics: Annexin A5; Antigens, Surface; Blood Platelets; Collagen; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Ionomycin; Membrane Proteins; Milk Proteins; Phosphatidylserines; Phospholipid Transfer Proteins; Platelet Activation; Thrombin; Thromboplastin | 2005 |
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.
Topics: Aniline Compounds; Animals; Annexin A5; Blood Coagulation; Blood Platelets; Calcium; Cattle; Coagulants; Erythrocytes; Flow Cytometry; Fluorescein-5-isothiocyanate; Histones; Humans; Inflammation; Phenotype; Phosphatidylserines; Recombinant Proteins; Thromboplastin; Xanthenes | 2014 |
A study of the ultrasound-targeted microbubble destruction based triplex-forming oligodexinucleotide delivery system to inhibit tissue factor expression.
Topics: Animals; Carotid Arteries; Carotid Stenosis; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Fluorescein-5-isothiocyanate; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Lipids; Microbubbles; Oligodeoxyribonucleotides; Rats; Rats, Sprague-Dawley; RNA, Messenger; Shear Strength; Sonication; Thromboplastin; Transfection | 2015 |